Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 13, 2011

Premium

Jeff Fitzgerald has joined Expression Analysis as director of business development.

Fitzgerald previously held sales positions at RainDance Technologies and Affymetrix. While at Affy, he supported "key genome and academic research centers in the use of expression, resequencing, and genotyping microarrays," EA said.
He holds a BS in microbiology and molecular genetics from the University of Vermont.


Orion Genomics has named Steven Smith as its vice president of bioinformatics.

Prior to joining Orion, Smith was owner of Genesmith Informatics, a consulting firm specializing in bioinformatics support, software development, and genome analysis. Previously, he served as vice president of bioinformatics at NimbleGen Systems, now Roche NimbleGen, where he supported the firm's custom microarray manufacturing and services. He also held positions at Millipore and Genetics Computer Group.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.